Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency

被引:2
作者
Chikasawa, Yushi [1 ]
Shinozawa, Keiko [2 ]
Amano, Kagehiro [1 ,2 ]
Ogata, Kyoichi [1 ]
Hagiwara, Takeshi [1 ]
Suzuki, Takashi [1 ]
Inaba, Hiroshi [1 ]
Fukutake, Katsuyuki [1 ,2 ]
机构
[1] Tokyo Med Univ, Dept Lab Med, Shinjuku Ku, Tokyo 1600023, Japan
[2] Tokyo Med Univ, Dept Mol Genet Coagulat Disorders, Shinjuku Ku, Tokyo 1600023, Japan
关键词
Factor X deficiency; Missense mutation; Recombinant expression study; Cross-reacting material-reduced deficiency; Homozygous mutation; BLOOD-COAGULATION FACTOR; FACTOR-IX; FX DEFICIENCY; STUART FACTOR; FACTOR VIIA; GLA-DOMAIN; ACTIVATION; GENE; RECOGNITION; INITIATION;
D O I
10.1007/s12185-014-1643-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated a mildly hemorrhagic patient with factor X (FX) deficiency to identify the nature of his defect by comprehensive analyses. A 42-year-old Japanese man was admitted to our hospital for uncontrolled gingival hemorrhage. His FX activity based on prothrombin time (PT) and activated partial thromboplastin time (aPTT) and FX antigen were < 1, 6.5 and 11 %, respectively. A homozygous M402T missense mutation (c.1205 t > c; p.Met402Thr) was identified in the FX gene (F10) from both the patient and his brother. The mutation was not detected in the F10 of 82 unrelated normal Japanese individuals. We studied the functional consequences of this mutation by expressing mutant FX-M402T protein in HEK293 cells. This analysis revealed that the antigen of the FX-M402T mutants was approximately 26 % that of the wild-type FX in conditioned media. The FX-specific activity of FX-M402T mutants measured by a one-stage clotting assay based upon PT and aPTT, and a chromogenic assay using Russell's viper venom in the concentrated media was 7.7, 31.7, and 41.2 % of wild type, respectively. The results suggest that the mutation FX-M402T may cause a secretion defect and a molecular abnormality in FX.
引用
收藏
页码:345 / 352
页数:8
相关论文
共 36 条
[1]  
BODE W, 1992, PROTEIN SCI, V1, P426
[2]   Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases [J].
Butenas, S ;
vantVeer, C ;
Mann, KG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) :21527-21533
[3]   THE COAGULATION CASCADE - INITIATION, MAINTENANCE, AND REGULATION [J].
DAVIE, EW ;
FUJIKAWA, K ;
KISIEL, W .
BIOCHEMISTRY, 1991, 30 (43) :10363-10370
[4]   ACTIVATION OF HUMAN FACTOR-X (STUART FACTOR) BY A PROTEASE FROM RUSSELLS VIPER VENOM [J].
DISCIPIO, RG ;
HERMODSON, MA ;
DAVIE, EW .
BIOCHEMISTRY, 1977, 16 (24) :5253-5260
[5]  
DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022
[6]   THE MOLECULAR-BASIS OF BLOOD-COAGULATION [J].
FURIE, B ;
FURIE, BC .
CELL, 1988, 53 (04) :505-518
[7]  
Furie B.C., 1976, Methods Enzymol, V45, P191
[8]   Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency [J].
Giansily-Blaizot, M ;
Aguilar-Martinez, P ;
Biron-Andreani, C ;
Janjean, P ;
Igual, H ;
Schved, JF .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (02) :105-112
[9]   A new mutation (Arg251Trp) in the Ca2+ binding site of factor X protease domain appears to be responsible for the defect in the extrinsic pathway activation of Factor X Padua [J].
Girolami, A ;
Vianello, F ;
Cabrio, L ;
Lombardi, AM .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2004, 10 (01) :5-8
[10]   Unexplained Discrepancies in the Activity-Antigen Ratio in Congenital FX Deficiencies With Defects in the Catalytic Domain [J].
Girolami, A. ;
Scarparo, P. ;
Vettore, S. ;
Candeo, N. ;
Scandellari, R. ;
Lombardi, A. M. .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (06) :621-627